Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Synchrony Financial - Preferred Stock (NYSE:SYF.PRB) from Neutral to Buy. What is the Fund Sentiment? There are 39 funds or ...

Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Synchrony Financial - Preferred Stock (NYSE:SYF.PRA) ...

Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...

MicroStrategy stock inches up following SEC filings that confirmed the company loaded up on more than 4,000 bitcoins. Crypto ...

GrabAGun, an online firearms retailer, completed its business combination with Colombier Acquisition Corp. II (CLBR) and is set to begin trading on the New York Stock Exchange under the ticker symbols ...

Carlsmed, a spine surgery solution company, announced today that it launched its initial public offering with the start of an ...

Authorities at Tehran's Evin Prison were still attending to the dead and wounded on the evening of June 23 when one of the highest-profile inmates held there, Swedish-Iranian scientist Ahmadreza ...

McGraw Hill aims for a $4.2 billion valuation in its IPO, planning to raise $537 million to repay debt and expand its ...

The Centers for Medicare & Medicaid Services (CMS) has proposed eliminating product-specific reimbursement for skin substitutes. Instead, these products would be treated as "incident-to supplies," a ...

Steris (STE) stock and Solventum (SOLV) stock is upgraded, while RxSight (RXST) stock is downgraded at Morgan Stanley on valuations. Read more here.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $26.5, a high estimate of $36.00, and a low estimate of $20.00. This current average represents a 31.17% ...

An in-depth analysis of recent analyst actions unveils how financial experts perceive Super Group (SGHC). The following ...